// App-Quantinova.ai

567 : Clinical outcomes of estrogen receptor (ER)-negative and progesterone receptor (PgR)-positive invasive breast cancer.

Researchers

Presenter

  • Melissa Chan

Principal Investigators

  • Martin Chang

  • Rosa Gonzalez

  • Francisco Emilio Vera-Badillo

  • Paula Quesada

  • Robyn Goldstein

  • Ignacio Cruz

  • Alberto Ocana

  • Juan J. Cruz

  • Eitan Amir

  • Belinda Lategan

  • Elvira del Barco

Medical Centers

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Medical Oncology Department, Salamanca University Hospital, Salamanca, SpainPrincess Margaret Cancer Centre - University Health Network, Department of Medicine, University of Toronto, Toronto, ON, CanadaDepartment of Pathology and Laboratory Medicine, Mount Sinai Hospital and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Progesterone receptor

  • Transthyretin

Drug/Treatment

  • N/A

Outcome

  • Indeterminate

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved